Status:
COMPLETED
Pilot Study of APD209 in Cancer Cachexia
Lead Sponsor:
Acacia Pharma Ltd
Conditions:
Cancer-related Cachexia
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Primary Objective: To assess the efficacy of APD209 in adult patients with active cachexia associated with advanced malignancy and not caused by simple starvation. Secondary Objective: To assess th...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Involuntary loss of weight of \>= 2% in 2 months or \>= 5% in 6 months, and ongoing in recent weeks, without (or with successfully treated) secondary causes of impaired oral nutritional intake (simple starvation).
Exclusion
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2012
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT00895726
Start Date
March 1 2009
End Date
January 1 2012
Last Update
January 13 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Infirmary Edinburgh
Edinburgh, United Kingdom